Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 88 pembrolizumab 77 Pemetrexed 65 Cisplatin 56 Paclitaxel 33 Docetaxel 31 durvalumab 28 atezolizumab 28 Nivolumab 28 Specimen Handling 25 Magnetic Resonance Spectroscopy 20 Gemcitabine 19 osimertinib 18 130-nm albumin-bound paclitaxel 18 Etoposide 17 Radiotherapy 14 Cetuximab 14 Platinum 12 Taxes 11 Immunoglobulin G 10 1,2-diaminocyclohexaneplatinum II citrate 10 Radiation 9 Ipilimumab 9 Disulfides 9 Bevacizumab 9 amivantamab 8 Topotecan 8 fludarabine 7 Ramucirumab 7 Radiosurgery 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NPI 2358 × Thoracic × 30 days × Clear all

NCT02504489 2026-05-19

DUBLIN-3

BeyondSpring Pharmaceuticals Inc.

Phase 3 Completed

559 enrolled 32 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡